LGT Capital Partners LTD. grew its stake in shares of UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 43.2% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 288,330 shares of the healthcare conglomerate’s stock after purchasing an additional 87,047 shares during the quarter. UnitedHealth Group comprises about 4.2% of LGT Capital Partners LTD.’s portfolio, making the stock its 5th biggest holding. LGT Capital Partners LTD.’s holdings in UnitedHealth Group were worth $ 147,040,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also bought and sold shares of UNH. Outfitter Financial LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $ 25,000. Blue Bell Private Wealth Management LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $ 29,000. Advocacy Wealth Management Services LLC grew its holdings in UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $ 30,000 after buying an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. grew its holdings in UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $ 31,000 after buying an additional 30 shares in the last quarter. Finally, Tortoise Investment Management LLC grew its holdings in UnitedHealth Group by 54.8% in the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $ 33,000 after buying an additional 23 shares in the last quarter. 87.48% of the stock is currently owned by institutional investors and hedge funds.
UNH stock opened at $ 499.81 on Friday. The stock’s 50 day moving average is $ 495.86 and its 200-day moving average is $ 491.14. The firm has a market capitalization of $ 468.91 billion, a PE ratio of 27.36, a P / E / G ratio of 1.50 and a beta of 0.83. UnitedHealth Group Incorporated has a twelve month low of $ 383.12 and a twelve month high of $ 553.29. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54.
UnitedHealth Group (NYSE: UNH – Get Rating) last issued its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 EPS for the quarter, topping analysts’ consensus estimates of $ 5.40 by $ 0.09. The business had revenue of $ 80.15 billion for the quarter, compared to analyst estimates of $ 78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. UnitedHealth Group’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period last year, the company posted $ 5.31 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be given a $ 1.65 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $ 1.45. This represents a $ 6.60 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 36.12%.
In related news, Director Frederick William Mcnabb III purchased 89 shares of UnitedHealth Group stock in a transaction dated Thursday, May 26th. The stock was bought at an average cost of $ 504.32 per share, for a total transaction of $ 44,884.48. Following the completion of the transaction, the director now owns 11,259 shares in the company, valued at $ 5,678,138.88. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $ 478.96, for a total value of $ 1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares of the company stock, valued at $ 581,936,400. The disclosure for this sale can be found here. Company insiders own 0.40% of the company stock.
A number of research firms have recently weighed in on UNH. Morgan Stanley upped their target price on UnitedHealth Group from $ 570.00 to $ 577.00 and gave the company an “overweight” rating in a research report on Monday, April 18th. Truist Financial upped their price objective on UnitedHealth Group from $ 575.00 to $ 610.00 in a research report on Thursday, April 7th. Cowen upped their price objective on UnitedHealth Group from $ 512.00 to $ 596.00 in a research report on Monday, April 18th. Oppenheimer increased their target price on UnitedHealth Group from $ 550.00 to $ 600.00 and gave the company an “outperform” rating in a research report on Monday, April 18th. Finally, SVB Leerink increased their target price on UnitedHealth Group from $ 550.00 to $ 600.00 and gave the company an “outperform” rating in a research report on Tuesday, April 19th. Three investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $ 555.73.
UnitedHealth Group Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE: UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.